These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 3539000)
1. Neurofibrillary degeneration of cholinergic and noncholinergic neurons of the basal forebrain in Alzheimer's disease. Rasool CG; Svendsen CN; Selkoe DJ Ann Neurol; 1986 Oct; 20(4):482-8. PubMed ID: 3539000 [TBL] [Abstract][Full Text] [Related]
2. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease. Wu CK; Thal L; Pizzo D; Hansen L; Masliah E; Geula C Exp Neurol; 2005 Oct; 195(2):484-96. PubMed ID: 16085017 [TBL] [Abstract][Full Text] [Related]
3. Cytoskeletal immunohistochemistry of Alzheimer's disease. Ulrich J; Anderton BH; Brion JP; Euler M; Probst A J Neural Transm Suppl; 1987; 24():197-204. PubMed ID: 3479523 [TBL] [Abstract][Full Text] [Related]
4. Evidence that transmitter-containing dystrophic neurites precede paired helical filament and Alz-50 formation within senile plaques in the amygdala of nondemented elderly and patients with Alzheimer's disease. Benzing WC; Ikonomovic MD; Brady DR; Mufson EJ; Armstrong DM J Comp Neurol; 1993 Aug; 334(2):176-91. PubMed ID: 7690048 [TBL] [Abstract][Full Text] [Related]
5. Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function. Gibbs RB Exp Neurol; 1998 Jun; 151(2):289-302. PubMed ID: 9628764 [TBL] [Abstract][Full Text] [Related]
6. The cholinergic system in aging and neuronal degeneration. Schliebs R; Arendt T Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918 [TBL] [Abstract][Full Text] [Related]
7. m2 muscarinic acetylcholine receptor-immunoreactive neurons are not reduced within the nucleus basalis in Alzheimer's disease: relationship with cholinergic and galaninergic perikarya. Mufson EJ; Jaffar S; Levey AI J Comp Neurol; 1998 Mar; 392(3):313-29. PubMed ID: 9511920 [TBL] [Abstract][Full Text] [Related]
9. Nucleus raphe dorsalis in Alzheimer's disease: neurofibrillary tangles and loss of large neurons. Yamamoto T; Hirano A Ann Neurol; 1985 Jun; 17(6):573-7. PubMed ID: 4026228 [TBL] [Abstract][Full Text] [Related]
10. Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease. Lehéricy S; Hirsch EC; Cervera-Piérot P; Hersh LB; Bakchine S; Piette F; Duyckaerts C; Hauw JJ; Javoy-Agid F; Agid Y J Comp Neurol; 1993 Apr; 330(1):15-31. PubMed ID: 8468401 [TBL] [Abstract][Full Text] [Related]
11. Properties of antigenic determinants that distinguish neurofibrillary tangles in progressive supranuclear palsy and Alzheimer's disease. Schmidt ML; Lee VM; Hurtig H; Trojanowski JQ Lab Invest; 1988 Oct; 59(4):460-6. PubMed ID: 2459498 [TBL] [Abstract][Full Text] [Related]
12. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex. van de Nes JA; Nafe R; Schlote W Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153 [TBL] [Abstract][Full Text] [Related]
13. Long-term effects of selective immunolesions of cholinergic neurons of the nucleus basalis magnocellularis on the ascending cholinergic pathways in the rat: a model for Alzheimer's disease. Szigeti C; Bencsik N; Simonka AJ; Legradi A; Kasa P; Gulya K Brain Res Bull; 2013 May; 94():9-16. PubMed ID: 23357177 [TBL] [Abstract][Full Text] [Related]
14. Neurofibrillary pathology and aluminum in Alzheimer's disease. Shin RW; Lee VM; Trojanowski JQ Histol Histopathol; 1995 Oct; 10(4):969-78. PubMed ID: 8574016 [TBL] [Abstract][Full Text] [Related]
15. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia. Chan-Palay V J Comp Neurol; 1988 Jul; 273(4):543-57. PubMed ID: 2463283 [TBL] [Abstract][Full Text] [Related]
16. Neurofibrillary tangles in cholinergic pedunculopontine neurons in Alzheimer's disease. Mufson EJ; Mash DC; Hersh LB Ann Neurol; 1988 Nov; 24(5):623-9. PubMed ID: 3202615 [TBL] [Abstract][Full Text] [Related]
17. HDAC2 dysregulation in the nucleus basalis of Meynert during the progression of Alzheimer's disease. Mahady L; Nadeem M; Malek-Ahmadi M; Chen K; Perez SE; Mufson EJ Neuropathol Appl Neurobiol; 2019 Jun; 45(4):380-397. PubMed ID: 30252960 [TBL] [Abstract][Full Text] [Related]
18. Decreased TrkA gene expression in cholinergic neurons of the striatum and basal forebrain of patients with Alzheimer's disease. Boissiere F; Faucheux B; Ruberg M; Agid Y; Hirsch EC Exp Neurol; 1997 May; 145(1):245-52. PubMed ID: 9184126 [TBL] [Abstract][Full Text] [Related]
19. Loss of cholinergic pathways in vascular dementia of the Binswanger type. Tomimoto H; Ohtani R; Shibata M; Nakamura N; Ihara M Dement Geriatr Cogn Disord; 2005; 19(5-6):282-8. PubMed ID: 15785029 [TBL] [Abstract][Full Text] [Related]